BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bleotu C, Chifiriuc MC, Grigore R, Grancea C, Popescu CR, Anton G, Cernescu C. Investigation of Th1/Th2 cytokine profiles in patients with laryngo-pharyngeal, HPV-positive cancers. Eur Arch Otorhinolaryngol 2013;270:711-8. [DOI: 10.1007/s00405-012-2067-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Brustin R, Toledano M, Geffen T, Goona R, Hochberg M, Kreisberg B, Murad S, Pitcovski J. Immune Modulation and Treatment of Human Papilloma Virus-Related Warts with Energetics of Living Systems Acupuncture. Med Acupunct 2017;29:145-54. [PMID: 28736591 DOI: 10.1089/acu.2017.1225] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Romanova Y, Laikov A, Markelova M, Khadiullina R, Makseev A, Hasanova M, Rizvanov A, Khaiboullina S, Salafutdinov I. Proteomic Analysis of Human Serum from Patients with Chronic Kidney Disease. Biomolecules 2020;10:E257. [PMID: 32046176 DOI: 10.3390/biom10020257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
3 Hong CC, Yao S, McCann SE, Dolnick RY, Wallace PK, Gong Z, Quan L, Lee KP, Evans SS, Repasky EA, Edge SB, Ambrosone CB. Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat 2013;139:477-88. [PMID: 23624818 DOI: 10.1007/s10549-013-2549-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
4 Sotirović J, Perić A, Vojvodić D, Baletić N, Zaletel I, Stanojević I, Erdoglija M, Milojević M. Serum cytokine profile of laryngeal squamous cell carcinoma patients. J Laryngol Otol 2017;131:455-61. [PMID: 28294085 DOI: 10.1017/S0022215117000573] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
5 Du GH, Wang JK, Richards JR, Wang JJ. Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer. Int Immunopharmacol 2019;66:154-61. [PMID: 30453149 DOI: 10.1016/j.intimp.2018.11.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
6 Pottier C, Wheatherspoon A, Roncarati P, Longuespée R, Herfs M, Duray A, Delvenne P, Quatresooz P. The importance of the tumor microenvironment in the therapeutic management of cancer. Expert Rev Anticancer Ther 2015;15:943-54. [PMID: 26098949 DOI: 10.1586/14737140.2015.1059279] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
7 Lazarenko LM, Nikitina OE, Nikitin EV, Demchenko OM, Kovtonyuk GV, Ganova LO, Bubnov RV, Shevchuk VO, Nastradina NM, Bila VV, Spivak MY. Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions. EPMA J 2014;5:1. [PMID: 24386936 DOI: 10.1186/1878-5085-5-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
8 Kwon M, Kim JW, Roh J, Park Y, Cho K, Choi S, Nam SY, Kim SY, Lee B. Recurrence and cancer-specific survival according to the expression of IL-4Rα and IL-13Rα1 in patients with oral cavity cancer. European Journal of Cancer 2015;51:177-85. [DOI: 10.1016/j.ejca.2014.11.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
9 Krzystek-Korpacka M, Zawadzki M, Kapturkiewicz B, Lewandowska P, Bednarz-Misa I, Gorska S, Witkiewicz W, Gamian A. Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer. Cytokine 2018;110:435-41. [PMID: 29801973 DOI: 10.1016/j.cyto.2018.05.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]